An open label study of the effects of rituximab in neuromyelitis optica. [electronic resource]
Producer: 20060210Description: 1270-2 p. digitalISSN:- 1526-632X
- Adult
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- B-Lymphocytes -- drug effects
- Disability Evaluation
- Female
- Humans
- Immunologic Factors -- administration & dosage
- Lymphocyte Count
- Male
- Myelitis, Transverse -- drug therapy
- Neuromyelitis Optica -- drug therapy
- Optic Nerve -- drug effects
- Optic Neuritis -- drug therapy
- Recovery of Function -- drug effects
- Rituximab
- Secondary Prevention
- Spinal Cord -- drug effects
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.